Evidence map›Paper›PMID 24931605›Full record

ArticleCell reports2014

A conditional system to specifically link disruption of protein-coding function with reporter expression in mice.

Shin-Heng Chiou, Caroline Kim-Kiselak, Viviana I Risca, Megan K Heimann, Chen-Hua Chuang, Aurora A Burds, William J Greenleaf, Tyler E Jacks, David M Feldser, Monte M Winslow

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Shin-Heng ChiouDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120, USA.
Caroline Kim-KiselakDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Viviana I RiscaDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120, USA.
Megan K HeimannDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Chen-Hua ChuangDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120, USA.
Aurora A BurdsDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
William J GreenleafDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120, USA.
Tyler E JacksDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
David M FeldserDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104-6160, USA; Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104-6160, USA.
Monte M WinslowDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5324, USA; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305-5456, USA. Electronic address: mwinslow@stanford.edu.
Stanford University · USMassachusetts Institute of Technology · USHoward Hughes Medical Institute · USUniversity of Pennsylvania · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Functional Characterization of Lung Adenocarcinoma Progression and MetastasisR00CA151968 · NCI · STANFORD UNIVERSITY · PI WINSLOW, MONTE MEIER · 2012 to 2014
$718k
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppressionR00CA158581 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FELDSER, DAVID · 2013 to 2015
$707k
Establishing therapeutic efficacy and uncovering mechanisms of tumor suppressionK99CA158581 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FELDSER, DAVID · 2011 to 2012
$233k
Functional Characterization of Lung Adenocarcinoma Progression and MetastasisK99CA151968 · NCI · STANFORD UNIVERSITY · PI WINSLOW, MONTE MEIER · 2010 to 2011
$225k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA014051NCI NIH HHS P30 CA124435NCI NIH HHS P30-CA124435NCI NIH HHS P30-CA14051NCI NIH HHS R00 CA151968NCI NIH HHS R00-CA151968NCI NIH HHS R00 CA158581NCI NIH HHS R00-CA158581
6 · The paper itself

Abstract

Conditional gene deletion in mice has contributed immensely to our understanding of many biological and biomedical processes. Despite an increasing awareness of nonprotein-coding functional elements within protein-coding transcripts, current gene-targeting approaches typically involve simultaneous ablation of noncoding elements within targeted protein-coding genes. The potential for protein-coding genes to have additional noncoding functions necessitates the development of novel genetic tools capable of precisely interrogating individual functional elements. We present a strategy that couples Cre/loxP-mediated conditional gene disruption with faithful GFP reporter expression in mice in which Cre-mediated stable inversion of a splice acceptor-GFP-splice donor cassette concurrently disrupts protein production and creates a GFP fusion product. Importantly, cassette inversion maintains physiologic transcript structure, thereby ensuring proper microRNA-mediated regulation of the GFP reporter, as well as maintaining expression of nonprotein-coding elements. To test this potentially generalizable strategy, we generated and analyzed mice with this conditional knockin reporter targeted to the Hmga2 locus.

Indexed as

Genes, ReporterAnimalsFemaleGene TargetingGreen Fluorescent ProteinsMaleMiceRecombination, GeneticGreen Fluorescent Proteins

Identifiers

PMID24931605
PMCPMC4113058
OpenAlexW2025894670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.